deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT00968760

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

Sponsor: Alaunos Therapeutics

Conditions B-cell Lymphoma Lymphoma
Interventions CD19-specific T Cell Infusion Carmustine Cytarabine Etoposide IL-2 Leukapheresis Melphalan Stem Cell Transplant
Updated 13 times since 2017 Last updated: Dec 13, 2023 Started: Jun 20, 2011 Primary completion: Apr 23, 2020 Completion: Apr 23, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates B-cell Lymphoma and Lymphoma and is currently completed. Alaunos Therapeutics leads this study, which shows 13 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jan 2018 · 11 months · monthly snapshot~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~Jun 2019 · 4 months · monthly snapshot~Jun 2019 – ~Feb 2020 · 8 months · monthly snapshot~Feb 2020 – ~Jul 2020 · 5 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshot~Mar 2022 – ~Jan 2024 · 22 months · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2024 — Jul 2024 [monthly]

    Completed PHASE1

  4. Mar 2022 — Jan 2024 [monthly]

    Completed PHASE1

  5. Jan 2021 — Mar 2022 [monthly]

    Completed PHASE1

▶ Show 8 earlier versions

  1. Jul 2020 — Jan 2021 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  2. Feb 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE1

  3. Jun 2019 — Feb 2020 [monthly]

    Active Not Recruiting PHASE1

  4. Feb 2019 — Jun 2019 [monthly]

    Active Not Recruiting PHASE1

  5. Jun 2018 — Feb 2019 [monthly]

    Active Not Recruiting PHASE1

  6. Jan 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1

  7. Feb 2017 — Jan 2018 [monthly]

    Active Not Recruiting PHASE1

  8. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE1

    First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alaunos Therapeutics
  • Intrexon Corporation
  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations